BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17419585)

  • 1. Using small-angle neutron scattering to study the solution conformation of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates.
    Paul A; Vicent MJ; Duncan R
    Biomacromolecules; 2007 May; 8(5):1573-9. PubMed ID: 17419585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
    Etrych T; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
    Ding H; Kopecková P; Kopecek J
    J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
    Duncan R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1131-48. PubMed ID: 19699249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug mimic induced conformational changes in model polymer-drug conjugates characterized by small-angle neutron scattering.
    Paul A; James C; Heenan RK; Schweins R
    Biomacromolecules; 2010 Aug; 11(8):1978-82. PubMed ID: 20593879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
    Studenovsky M; Ulbrich K; Ibrahimova M; Rihova B
    Eur J Pharm Sci; 2011 Jan; 42(1-2):156-63. PubMed ID: 21075206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells.
    Shamay Y; Paulin D; Ashkenasy G; David A
    Biomaterials; 2009 Nov; 30(32):6460-8. PubMed ID: 19716600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.
    Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M
    J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
    Yeung TK; Hopewell JW; Simmonds RH; Seymour LW; Duncan R; Bellini O; Grandi M; Spreafico F; Strohalm J; Ulbrich K
    Cancer Chemother Pharmacol; 1991; 29(2):105-11. PubMed ID: 1760851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
    Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
    Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R; Gac-Breton S; Keane R; Musila R; Sat YN; Satchi R; Searle F
    J Control Release; 2001 Jul; 74(1-3):135-46. PubMed ID: 11489490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macromolecular HPMA-based nanoparticles with cholesterol for solid-tumor targeting: detailed study of the inner structure of a highly efficient drug delivery system.
    Filippov SK; Chytil P; Konarev PV; Dyakonova M; Papadakis C; Zhigunov A; Plestil J; Stepanek P; Etrych T; Ulbrich K; Svergun DI
    Biomacromolecules; 2012 Aug; 13(8):2594-604. PubMed ID: 22793269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.